首页|屈他维林注射液所致药物不良反应的临床特征分析

屈他维林注射液所致药物不良反应的临床特征分析

扫码查看
目的:分析屈他维林注射液所致药物不良反应(adverse drug reactions,ADRs)的临床特征,为临床屈他维林注射液的用药安全提供参考。方法:采集 2019 年 1 月—2021 年 12 月苏州九龙医院上报的 64 例屈他维林注射液所致ADRs报告作为研究资料,采集其中患者的年龄、性别和屈他维林注射液的用法用量,以及ADRs的发生时间、临床表现和最终转归等信息,分析屈他维林注射液所致ADRs的发生特点和规律。结果:64 例屈他维林注射液所致ADRs中,>20~40 岁患者的占比最高(45 例,占 70。31%),屈他维林的单次用量多为 80 mg(58 例,占90。62%),ADRs的发生时间主要为用药后的 30 min内(45 例,占 70。31%),ADRs累及的器官主要为皮肤及其附件(61 例,发生率为 95。31%);关于患者的转归,52 例患者在停用屈他维林注射液后症状自行缓解,其余 12 例在对症处理后也均好转。结论:屈他维林注射液所致ADRs在患者年龄、给药剂量、发生时间和累及器官方面有着较为明显的特点,临床对于相关患者应当加强监护,以保证患者的用药安全。
Analysis of Clinical Characteristics of Adverse Drug Reactions Caused by Drotaverine Injection
Objective:To analyze the clinical characteristics of adverse drug reactions(ADRs)caused by drotaverine injection,and provide reference for the clinical medication safety of drotaverine injection.Methods:The reports of 64 cases with ADRs caused by drotaverine injection submitted by Suzhou Kowloon Hospital from January 2019 to December 2021 were collected as the research materials;the information such as patient's age,gender,usage and dosage of drotaverine injection,as well as occurrence time,clinical manifestations and final outcomes of ADRs was collected to analyze the occurrence characteristics and rules of ADRs caused by drotaverine injection.Results:Among 64 cases with ADRs caused by drotaverine injection,patients aged 20 to 40 years accounted for the highest proportion(45 cases,70.31%),the single dose of drotaverine was mostly 80 mg(58 cases,90.62%),the occurrence time of ADRs was mainly within 30 minutes after medication(45 cases,70.31%),and the organs involved by ADRs were mainly the skin and its appendages(61 cases,incidence of 95.31%).Regarding outcomes of patients,the symptoms of 52 patients relieved spontaneously after discontinuing drotaverine injection,and the remaining 12 patients also improved after symptomatic treatment.Conclusion:ADRs caused by drotaverine injection have obvious characteristics in terms of patient's age,dosage of administration,occurrence time and organs involved.Clinical monitoring should be strengthened for related patients to ensure their medication safety.

drotaverine injectionadverse drug reactionsclinical characteristics

刘鑫炎、朱芹汶、鲁继光、田敬林

展开 >

上海交通大学医学院苏州九龙医院药学部,江苏 苏州 215028

屈他维林注射液 药物不良反应 临床特征

2024

抗感染药学
江苏省苏州市第五人民医院

抗感染药学

影响因子:0.505
ISSN:1672-7878
年,卷(期):2024.21(3)
  • 10